News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
734,347 Results
Type
Article (41806)
Company Profile (290)
Press Release (692235)
Multimedia
Podcasts (100)
Webinars (20)
Section
Business (205793)
Career Advice (2045)
Deals (35712)
Drug Delivery (132)
Drug Development (81740)
Employer Resources (173)
FDA (16545)
Job Trends (15041)
News (348163)
Policy (32861)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2614)
Accelerated approval (48)
Adcomms (26)
Allergies (171)
Alliances (49926)
ALS (212)
Alzheimer's disease (1809)
Antibody-drug conjugate (ADC) (462)
Approvals (16937)
Artificial intelligence (675)
Autoimmune disease (297)
Automation (56)
Bankruptcy (365)
Best Places to Work (11657)
BIOSECURE Act (21)
Biosimilars (224)
Biotechnology (185)
Bladder cancer (197)
Brain cancer (72)
Breast cancer (757)
Cancer (5877)
Cardiovascular disease (476)
Career advice (1738)
Career pathing (43)
CAR-T (336)
CDC (57)
Celiac Disease (3)
Cell therapy (914)
Cervical cancer (47)
Clinical research (71044)
Collaboration (2097)
Company closure (5)
Compensation (1409)
Complete response letters (80)
COVID-19 (2760)
CRISPR (109)
C-suite (1150)
Cystic fibrosis (154)
Data (7991)
Decentralized trials (3)
Denatured (33)
Depression (163)
Dermatology (87)
Diabetes (589)
Diagnostics (6959)
Digital health (55)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (329)
Drug pricing (204)
Drug shortages (31)
Duchenne muscular dystrophy (287)
Earnings (92281)
Editorial (66)
Employer branding (21)
Employer resources (152)
Events (120184)
Executive appointments (1093)
FDA (20302)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (34)
Funding (1752)
Gene editing (238)
Generative AI (56)
Gene therapy (730)
GLP-1 (1062)
Government (4749)
Grass and pollen (6)
Guidances (408)
Healthcare (19036)
HIV (79)
Huntington's disease (57)
IgA nephropathy (97)
Immunology and inflammation (297)
Immuno-oncology (95)
Indications (196)
Infectious disease (3108)
Inflammatory bowel disease (220)
Inflation Reduction Act (16)
Influenza (137)
Intellectual property (293)
Interviews (319)
IPO (16700)
IRA (52)
Job creations (3682)
Job search strategy (1443)
JPM (58)
Kidney cancer (19)
Labor market (102)
Layoffs (574)
Leadership (40)
Legal (7989)
Liver cancer (100)
Longevity (33)
Lung cancer (772)
Lymphoma (430)
Machine learning (60)
Management (59)
Manufacturing (1064)
MASH (190)
Medical device (13953)
Medtech (14081)
Mergers & acquisitions (20264)
Metabolic disorders (1514)
mRNA (213)
Multiple sclerosis (189)
NASH (17)
Neurodegenerative disease (422)
Neuropsychiatric disorders (106)
Neuroscience (3333)
Neurotech (1)
NextGen: Class of 2026 (6557)
Non-profit (4541)
Now hiring (78)
Obesity (710)
Opinion (292)
Ovarian cancer (223)
Pain (259)
Pancreatic cancer (311)
Parkinson's disease (363)
Partnered (35)
Patents (600)
Patient recruitment (679)
Peanut (62)
People (59980)
Pharmaceutical (60)
Pharmacy benefit managers (32)
Phase 1 (22164)
Phase 2 (31304)
Phase 3 (23275)
Pipeline (8888)
Policy (322)
Postmarket research (2570)
Preclinical (9460)
Press Release (64)
Prostate cancer (307)
Psychedelics (54)
Radiopharmaceuticals (325)
Rare diseases (1091)
Real estate (6018)
Recruiting (70)
Regulatory (25517)
Reports (56)
Research institute (2421)
Resumes & cover letters (354)
Rett syndrome (39)
RNA editing (25)
RSV (88)
Schizophrenia (178)
Series A (297)
Series B (216)
Service/supplier (13)
Sickle cell disease (112)
Special edition (24)
Spinal muscular atrophy (166)
Sponsored (48)
Startups (3697)
State (2)
Stomach cancer (18)
Supply chain (127)
Tariffs (88)
The Weekly (65)
Vaccines (1103)
Venture capital (111)
Weight loss (457)
Women's health (128)
Worklife (20)
Date
Today (128)
Last 7 days (673)
Last 30 days (3562)
Last 365 days (30362)
2026 (13084)
2025 (30328)
2024 (35318)
2023 (40175)
2022 (51287)
2021 (55831)
2020 (54151)
2019 (46640)
2018 (35120)
2017 (32220)
2016 (31628)
2015 (37705)
2014 (31454)
2013 (26499)
2012 (28770)
2011 (29426)
2010 (27525)
Location
Africa (745)
Alabama (93)
Alaska (7)
Arizona (350)
Arkansas (14)
Asia (39920)
Australia (6561)
California (13437)
Canada (3799)
China (1357)
Colorado (571)
Connecticut (579)
Delaware (411)
Europe (86474)
Florida (2007)
Georgia (430)
Hawaii (3)
Idaho (63)
Illinois (1059)
India (91)
Indiana (605)
Iowa (23)
Japan (540)
Kansas (132)
Kentucky (50)
Louisiana (42)
Maine (76)
Maryland (1601)
Massachusetts (9570)
Michigan (366)
Minnesota (729)
Mississippi (6)
Missouri (145)
Montana (33)
Nebraska (29)
Nevada (143)
New Hampshire (85)
New Jersey (3514)
New Mexico (29)
New York (3497)
North Carolina (1694)
North Dakota (9)
Northern California (6744)
Ohio (401)
Oklahoma (23)
Oregon (43)
Pennsylvania (2691)
Puerto Rico (29)
Rhode Island (50)
South America (1115)
South Carolina (86)
South Dakota (2)
Southern California (5300)
Tennessee (215)
Texas (2140)
United States (47291)
Utah (399)
Vermont (1)
Virginia (324)
Washington D.C. (81)
Washington State (1072)
West Virginia (4)
Wisconsin (127)
Wyoming (2)
734,347 Results for "neurocrine biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Neurocrine Biosciences Completes Acquisition of Soleno Therapeutics
May 18, 2026
·
10 min read
Press Releases
Neurocrine Biosciences Reports First-Quarter 2026 Financial Results
May 6, 2026
·
18 min read
Press Releases
Neurocrine Biosciences to Present at the Bank of America Health Care Conference 2026
May 5, 2026
·
1 min read
Mergers & acquisitions
Neurocrine Nabs Rare Obesity Disorder Drug in ‘Surprising’ $2.9B Soleno Deal
While an acquisition is a good exit for Soleno Therapeutics, the company’s acceptance of Neurocrine Biosciences’ $53-per-share offer came as a surprise to Stifel analysts given the potential growth of Vykat XR, approved last year for extreme hunger in patients with Prader-Willi syndrome.
April 6, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Neurocrine Biosciences Announces Publication Establishing Clinically Meaningful Improvement Threshold for the Tardive Dyskinesia Impact Scale
April 29, 2026
·
14 min read
Press Releases
Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2026 Financial Results
April 15, 2026
·
1 min read
Press Releases
Neurocrine Biosciences Presents Real-World Data Highlighting Functional Impact of Mild Tardive Dyskinesia Severity and Improvement with INGREZZA® (valbenazine) Capsules
May 18, 2026
·
15 min read
Press Releases
Neurocrine Biosciences to Present at the Stifel 2026 Virtual CNS Forum
March 11, 2026
·
1 min read
Press Releases
Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBIP-'2118, a Corticotropin-Releasing Factor Type 2 Receptor Agonist
May 4, 2026
·
5 min read
Press Releases
Neurocrine Biosciences Announces Publication of Expert Recommendations for Glucocorticoid Dose Reduction after Initiating CRENESSITY® (crinecerfont) for the Treatment of Classic Congenital Adrenal Hyperplasia
May 6, 2026
·
14 min read
1 of 73,435
Next
